730 Organometallics, Vol. 21, No. 4, 2002
Kraft et al.
Syn th esis of Cp *2Zr (o-C6F 4H)F , 2. In the drybox, a
solution of 60 mg (0.117 mmol) of Cp*2Zr(o-C6F4H)H in ∼1 mL
of pentane was prepared in a polyethylene reaction vessel.
With stirring, HF-pyridine (70% HF, 30% pyridine) (∼0.1 mL)
was added via syringe and vigorous H2 evolution occurred. The
solution was transferred to a glass vial to neutralize excess
HF and stripped to dryness. The residue was redissolved in
pentane, filtered, and stripped to dryness, yielding analytically
ing reductive elimination of an aryl-methylene bond
in 3 followed by C-F activation is also inconsistent with
the formation of benzyne-trapped products.
Con clu sion s
The thermal decomposition of Cp*2Zr(C6F5)H occurs
by dual pathways to give Cp*2Zr(o-C6F4H)F and Cp*-
(Fv)Zr(C6F5) by competing C-F and C-H bond activa-
tion pathways. Further reaction with Cp*(Fv)Zr(C6F5)
leads to formation of Cp*(C5Me4CH2(C6F4))ZrF, formed
by insertion of tetrafluorobenzyne into the Zr-CH2 bond
of the fulvene complex. In both C-F bond activation
reactions, tetrafluorobenzyne was trapped with durene
to form the Diels-Alder adduct.
pure Cp*2Zr(o-C6F4H)F (25 mg, 40%). Anal. Calcd for C26H31
-
ZrF5: C, 58.95; H, 5.90. Found: C, 58.70; H, 6.18.
Th er m olysis of Cp *2Zr (C6F 5)H u n d er H2. In a resealable
NMR tube, 12 mg (0.033 mmol) of Cp*2Zr(C6F5)H was added,
dissolved in cyclohexane-d12, and freeze-pump-thaw degassed
three times. H2 (1.3 atm) was admitted into the tube, and the
solution was heated in a thermostated 100 °C oil bath for 20
days, leading to quantitative conversion of Cp*2Zr(o-C6F4H)F.
1H NMR (C6D12): δ 1.786 (s, 30 H, Cp*), 6.63 (m, 1 H, Arf-H).
19F NMR (C6D12): δ 90.5 (s, 1 F, Zr-F), -113.9 (m, 1 F), -139.3
(m, 1 F), -157.9 (m, 1 F), -158.8 (m, 1 F).
Exp er im en ta l Section
Th er m olysis of Cp *2Zr (C6F 5)H u n d er Va cu u m . In a
sealable NMR tube, 29 mg of Cp*2Zr(C6F5)H was added and
dissolved in cyclohexane-d12. The solution was freeze-pump-
thaw degassed three times and sealed under vacuum. The tube
was then heated in a 80 °C oil bath. After 28 days, the starting
material was ∼92% depleted, yielding a 36:14:3:1 mixture of
Cp*(C5Me4CH2)Zr(C6F5), Cp*2Zr(C6F4H)F, Cp*(C5Me4CH2-
(C6F4))ZrF, and Cp*2ZrF2, respectively. For Cp*(C5Me4CH2)-
Zr(C6F5), 1H NMR (toluene-d8): δ 2.21 (dd, 1 H), 1.87 (dd, 1
H), 1.71 (d, 3 H), 1.66 (s, 15 H), 1.56 (s, 3 H), 1.33 (s, 3 H),
1.15 (d, 3 H). 19F NMR (toluene-d8): δ -114.6 (m, 1 F), -124.4
(d, 1 F), -156.0 (t, 1 F), -161.0 (quin, 1 F), -161.6 (quin, 1
F). For Cp*(C5Me4CH2(C6F4))ZrF, 1H NMR (C6D12): δ 3.75 (d,
J H-H ) 17.5 Hz, 1 H), 3.57 (d, J H-H ) 17.5 Hz, 1 H), 2.13 (s, 3
H), 2.12 (s, 3 H), 1.86 (s, 15 H), 1.73 (s, 3 H), 1.51 (s, 3 H). 19F
NMR (C6D12): δ 87.6 (br s, 1 F), -108.4 (m, 1 F), -140.6 (t, 1
F), -158.9 (m, 1 F), -160.1 (m, 1 F).
Gen er a l Con sid er a tion s. All manipulations were per-
formed inside a N2-filled Vacuum Atmospheres glovebox or on
a high-vacuum line. Cyclohexane and cyclohexane-d12 were
dried and vacuum distilled from purple solutions of benzophe-
none ketyl. UHP grade H2 (Air Products) was purified by
passage over activated 4 Å molecular sieves and MnO on
vermiculite. 1H and 19F NMR spectra were recorded using a
Bruker Avance400 spectrometer. 19F NMR spectra were ref-
erenced to R,R,R-trifluorotoluene (taken as δ -63.73 relative
to CFCl3 with downfield chemical shifts taken to be positive).
GC/MS analyses were conducted using a 5890A Series GC
equipped with a Restek RTX-5 column (0.25 mm i.d., 0.25 µm,
13 m) and a HP 5970 series mass selective detector. Cp*2ZrH2,
Hg(C6F5)2, Hg(o-C6F4H)2, and Cp*(C5Me4CH2)ZrCl were pre-
pared according to the literature procedures.8,13-15 Ca u tion :
Or ga n om er cu r y d er iva tives a r e h igh ly p oison ou s a n d
sh ou ld be h a n d led w ith gr ea t ca r e.14,16
Th er m olysis of Cp *2Zr (C6F 5)H in th e P r esen ce of
Du r en e (1,2,4,5-tetr a m eth ylben zen e). In a resealable NMR
tube, 18 mg (0.034 mmol) of Cp*2Zr(C6F5)H and 46 mg (0.34
mmol) of durene were dissolved in cyclohexane-d12. The tube
was then placed in a 120 °C oil bath for 4 days. Both Cp*2Zr-
(o-C6F4H)F and Cp*(C5Me4CH2(C6F4))ZrF were formed along
with the Diels-Alder adduct C6H2(CH3)4(C6F4) in 20% yield
by NMR integration. The solvent was replaced with THF-d8
for direct comparison of known chemical shifts.4 For C6H2-
(CH3)4(C6F4), 1H NMR (THF-d8): δ 4.57 (t, 2 H), 1.80 (s, 12
H). 19F NMR (THF-d8): δ -151.1 (m, 2 F), -163.6 (m, 2 F).
GC/MS (m/z): 282 (M+).
Syn th esis of Cp *(C5Me4CH2)Zr (C6F 5), 3. Into a 100 mL
Schlenk flask, 800 mg (2.01 mmol) Cp*(C5Me4CH2)ZrCl was
added and dissolved in ∼40 mL of diethyl ether. Into a second
round-bottomed flask, 246 µL (2.21 mmol, d ) 1.514 g/mL) of
pentafluorobenzene and ∼15 mL of diethyl ether were added
and cooled to -78 °C. n-Butyllithium (1.41 mL, 2.26 mmol,
1.60 M in hexanes) was added dropwise with stirring and
allowed to warm slowly to -20 °C followed by cooling to -78
°C. The resulting LiC6F5 solution was transferred via cannula
into the Cp*(C5Me4CH2)ZrCl solution at -78 °C, upon which
the solution gradually turned from orange to deep red. The
mixture was allowed to warm slowly to room temperature over
5 h. The solvent was replaced with pentane, filtered over
Celite, and concentrated. Crystallization and filtration at -78
°C afforded dark red crystals of Cp*(C5Me4CH2)Zr(C6F5) (600
mg, 56%). Anal. Calcd for C26H29ZrF5: C, 59.17; H, 5.54.
Found: C, 59.05; H, 5.71.
Syn th esis of Cp *2Zr (C6F 5)H, 1. In the drybox, a solution
of 200 mg (0.55 mmol) of Cp*2ZrH2 in ∼5 mL of pentane was
added dropwise to a slurry of 147 mg (0.275 mmol) of Hg(C6F5)2
in ∼5 mL of pentane at room temperature. Vigorous evolution
of H2 occurred, and elemental mercury was formed. The
mixture was stirred for 30 min, filtered over Celite, and
stripped to dryness, giving an orange crystalline mass of Cp*2-
Zr(C6F5)H (415 mg, 95%). Cp*2Zr(C6F5)H was recrystallized
from pentane at -30 °C to yield X-ray quality crystals. 1H
NMR (C6D12): δ 1.88 (s, 30 H, Cp*), 7.71 (dd, 1H, Zr(C6F5)H).
19F NMR (C6D12): δ -116.3 (m, 1 F), -117.7 (m, 1 F), -155.2
(t, 1 F), -160.2 (m, 1 F), -161.9 (m, 1 F). Anal. Calcd for
C
26H31ZrF5: C, 58.95; H, 5.90. Found: C, 59.04; H, 5.76.
P r ep a r a tion of Cp *2Zr (o-C6F 4H)H. A solution of 200 mg
(0.55 mmol) of Cp*2ZrH2 in ∼5 mL of pentane was added
dropwise to a slurry of 137 mg (0.275 mmol) of Hg(o-C6F4H)2
in ∼5 mL of pentane at room temperature. Vigorous evolution
of H2 and elemental mercury was observed. The mixture was
stirred for 30 min, filtered over Celite, and stripped to dryness.
The orange crystalline mass was dissolved in a minimum of
pentane and crystallized at -30 °C to yield X-ray quality
crystals of Cp*2Zr(o-C6F4H)H (177 mg, 63%). The X-ray
structure is included in the Supporting Information. For Cp*2-
1
Zr(o-C6F4H)H, H NMR (C6D12): δ 1.847 (s, 30 H, Cp*), 5.98
(m, 1 H, Zr-C6F4H), 6.83 (br, 1 H, ZrH). 19F NMR (C6D12): δ
-118.1 (m, 1 F), -139.8 (m, 1 F), -157.4 (m, 1 F), -159.0 (m,
1 F). Anal. Calcd for C26H32ZrF4: C, 61.02; H, 6.30. Found: C,
60.84; H, 6.08.
Th er m olysis of Cp *(C5Me4CH2)Zr (C6F 5). Into a reseal-
able NMR tube, 12 mg (0.023 mmol) of Cp*(C5Me4CH2)Zr(C6F5)
was dissolved in cyclohexane-d12. R,R,R-Trifluorotoluene (1.0
µL) was added as an internal standard. The tube was im-
mersed in a 120 °C oil bath for 4 days to give Cp*(C5Me4CH2-
(C6F4))ZrF in 58% yield by NMR integration with other
(13) Schock, L. E.; Marks, T. J . J . Am. Chem. Soc. 1988, 110, 7701.
(14) Albrecht, H. B.; Deacon, G. B.; Tailby, M. J . J . Organomet.
Chem. 1974, 70, 313.
(15) Tamborski, C.; Soloski, E. J . J . Organomet. Chem. 1979, 17,
185.
(16) Blayney, M. B.; Winn, J . S.; Nierenberg, D. W. Chem. Eng. News
1997, 75, (19), 7.